Skip to content
Disclosery

BML Capital Management, LLC

Follow

13F filer, CIK 1616824, ZIONSVILLE, IN

BML Capital Management, LLC reported $109,215,490 across 20 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-10. Its ten largest share positions make up 94.33% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001754960-25-000762

Period
2025-09-30
Reported value
$109M
Holdings
20
Top 10 weight
94.33%
New
7
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TILadded+110,701$1.98M
CNTBnew+1,267,500$1.91M
IMAnew+182,509$1.49M
LONAnew+323,066$1.34M
TGTnew+10,000$897K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ESSA PHARMA INCexited-4,221,546-$7.18M
IKENA ONCOLOGY INCexited-4,030,102-$5.4M
MISTexited-1,136,091-$2.2M
ELEVATION ONCOLOGY INC COMexited-5,890,434-$2.16M
CONNECT BIOPHARMA HLDGS LTDexited-1,821,558-$1.79M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001754960-25-000762, largest first. % of portfolio is the value over $108,696,752, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,250,000 shares; 2024Q4: 14,250,000 shares; 2025Q1: 14,250,000 shares; 2025Q2: 14,250,000 shares; 2025Q3: 14,250,000 shares 14,250,000$27.1M24.91%0Timeline
AVIRATEA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,650,000 shares; 2024Q4: 7,608,312 shares; 2025Q1: 7,609,812 shares; 2025Q2: 7,609,812 shares; 2025Q3: 7,473,963 shares 7,473,963$21.7M19.94%-135,849Timeline
ADVERUM BIOTECHNOLOGIES INCADVERUM BIOTECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,268,064 shares; 2024Q4: 2,268,064 shares; 2025Q1: 2,742,317 shares; 2025Q2: 3,057,526 shares; 2025Q3: 3,057,526 shares 3,057,526$13.9M12.74%0
TILINSTIL BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 335,000 shares; 2024Q4: 400,000 shares; 2025Q1: 416,720 shares; 2025Q2: 534,899 shares; 2025Q3: 645,600 shares 645,600$11.5M10.61%+110,701Timeline
ORMPORAMED PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,186,191 shares; 2024Q4: 2,643,907 shares; 2025Q1: 3,020,748 shares; 2025Q2: 3,083,253 shares; 2025Q3: 3,167,231 shares 3,167,231$8.36M7.69%+83,978Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,688,772 shares; 2024Q4: 3,466,684 shares; 2025Q1: 3,747,612 shares; 2025Q2: 5,000,000 shares; 2025Q3: 5,292,000 shares 5,292,000$7.41M6.82%+292,000Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 49,627 shares; 2025Q2: 1,210,415 shares; 2025Q3: 1,210,415 shares 1,210,415$4.83M4.44%0Timeline
LAVA THERAPEUTICS NVLAVA THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,960,610 shares; 2025Q2: 1,970,610 shares; 2025Q3: 1,970,610 shares 1,970,610$3.07M2.83%0
KZRKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 48,668 shares; 2025Q1: 408,138 shares; 2025Q2: 635,183 shares; 2025Q3: 720,787 shares 720,787$2.81M2.59%+85,604Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,267,500 shares 1,267,500$1.91M1.76%newTimeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 182,509 shares 182,509$1.49M1.37%newTimeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 323,066 shares 323,066$1.34M1.23%newTimeline
ASTCASTROTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 220,410 shares; 2024Q4: 220,410 shares; 2025Q1: 220,410 shares; 2025Q2: 220,410 shares; 2025Q3: 220,410 shares 220,410$1.08M0.99%0Timeline
TGTTARGET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares 10,000$897K0.83%newTimeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 150,000 shares; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares; 2025Q3: 150,000 shares 150,000$532K0.49%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares 50,000$426K0.39%newTimeline
LSTALISATA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 284,669 shares; 2024Q4: 284,669 shares; 2025Q1: 216,853 shares; 2025Q2: 209,814 shares; 2025Q3: 109,841 shares 109,841$288K0.26%-99,973Timeline
MURAL ONCOLOGY PUB LTD COMURAL ONCOLOGY PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 57,500 shares 57,500$119K0.11%new
THRDTHIRD HARMONIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,824,417 shares; 2025Q2: 3,824,417 shares; 2025Q3: 3,824,417 shares 3,824,417$00%0Value filed as zero, left out of ratios.Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
WMTWALMART INC COMput265$519Knew

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ESSA PHARMA INCESSA PHARMA INC4,221,546$7.18Mshares
IKENA ONCOLOGY INCIKENA ONCOLOGY INC4,030,102$5.4Mshares
MISTMILESTONE PHARMACEUTICALS IN1,136,091$2.2Mshares
ELEVATION ONCOLOGY INC COMELEVATION ONCOLOGY INC COM5,890,434$2.16Mshares
CONNECT BIOPHARMA HLDGS LTDCONNECT BIOPHARMA HLDGS LTD1,821,558$1.79Mshares
TSLATESLA INC200$1.65Mput
ATHIRA PHARMA INCATHIRA PHARMA INC3,230,667$976Kshares
CRVSCORVUS PHARMACEUTICALS INC118,766$475Kshares
TURNSTONE BIOLOGICS CORPTURNSTONE BIOLOGICS CORP1,103,386$396Kshares
HILLEVAX INCHILLEVAX INC91,913$183Kshares
VERRICA PHARMACEUTICALS INCVERRICA PHARMACEUTICALS INC174,651$92.6Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001754960-25-000762 base2025-11-10acceptance time not in the bulk data set